Literature DB >> 23408849

Sequence analysis of transplacentally acquired human herpesvirus 6 DNA is consistent with transmission of a chromosomally integrated reactivated virus.

Annie Gravel1, Caroline Breese Hall, Louis Flamand.   

Abstract

The majority of human herpesvirus 6 (HHV-6) congenital infections (86%) originate from germ line transmission of chromosomally integrated HHV-6 (ciHHV-6). To determine whether transplacentally acquired HHV-6 could derive from the transmission of reactivated maternal ciHHV-6, we identified mother-infant pairs in which infants had proven transplacentally acquired HHV-6 and mothers had documented ciHHV-6, and we sequenced and compared the HHV-6 gB gene sequences for each pair. Our data indicate that the gB gene sequence found in each cord blood specimen was identical to that of the corresponding mother but divergent from that of other known HHV-6 isolates. These results are consistent with transplacentally acquired HHV-6 originating from the transmission of reactivated ciHHV-6.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408849     DOI: 10.1093/infdis/jit060

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  The Brief Case: Inherited Chromosomally Integrated Human Herpesvirus 6 (HHV-6) in the Age of Multiplex HHV-6 Testing.

Authors:  Alexander L Greninger; Samia N Naccache; Pia Pannaraj; Keith R Jerome; Jennifer Dien Bard; Jeanne W Ruderman
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  Human herpesvirus 6 (HHV-6) alters E2F1/Rb pathways and utilizes the E2F1 transcription factor to express viral genes.

Authors:  Eyal Sharon; Ludmila Volchek; Niza Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-12       Impact factor: 11.205

3.  Cell Culture Systems To Study Human Herpesvirus 6A/B Chromosomal Integration.

Authors:  Annie Gravel; Isabelle Dubuc; Nina Wallaschek; Shella Gilbert-Girard; Vanessa Collin; Ruth Hall-Sedlak; Keith R Jerome; Yasuko Mori; Julie Carbonneau; Guy Boivin; Benedikt B Kaufer; Louis Flamand
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

4.  Stabilization of Telomere G-Quadruplexes Interferes with Human Herpesvirus 6A Chromosomal Integration.

Authors:  Shella Gilbert-Girard; Annie Gravel; Sara Artusi; Sara N Richter; Nina Wallaschek; Benedikt B Kaufer; Louis Flamand
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

Review 5.  Clinical impact of primary infection with roseoloviruses.

Authors:  Brenda L Tesini; Leon G Epstein; Mary T Caserta
Journal:  Curr Opin Virol       Date:  2014-10-14       Impact factor: 7.090

6.  Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris.

Authors:  Annie Gravel; Isabelle Dubuc; Guillaume Morissette; Ruth H Sedlak; Keith R Jerome; Louis Flamand
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

Review 7.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 8.  Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.

Authors:  M Ogata; T Fukuda; T Teshima
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

9.  Detection of Human Herpesvirus 6B (HHV-6B) Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR.

Authors:  Ruth Hall Sedlak; Joshua A Hill; Thuy Nguyen; Michelle Cho; Greg Levin; Linda Cook; Meei-Li Huang; Louis Flamand; Danielle M Zerr; Michael Boeckh; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2016-02-17       Impact factor: 5.948

Review 10.  Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials.

Authors:  Joshua A Hill; Danielle M Zerr
Journal:  Curr Opin Virol       Date:  2014-10-04       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.